Development of an optimized immuno-enzymosome formulation for application in cancer therapy

M.J. Fonseca, M.H. Vingerhoeds, H.J. Haisma, D.J.A. Crommelin, G. Storm

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Original language	Undefined/Unknown
Title of host publication	Future Strategies for Drug Delivery with Particulate Systems
Editors	J.E. Diederichs, R.H. Muller
Pages	152-157
Publication status	Published - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@inbook{11b47108fcc549709a85a3f655146b1d,

title = "Development of an optimized immuno-enzymosome formulation for application in cancer therapy",

author = "M.J. Fonseca and M.H. Vingerhoeds and H.J. Haisma and D.J.A. Crommelin and G. Storm",

note = "CRC Press, Medpharm GmbH Scient. Publ. Stuttgart, Germany",

year = "1998",

language = "Undefined/Unknown",

pages = "152--157",

editor = "J.E. Diederichs and R.H. Muller",

booktitle = "Future Strategies for Drug Delivery with Particulate Systems",

}

TY - CHAP

T1 - Development of an optimized immuno-enzymosome formulation for application in cancer therapy

AU - Fonseca, M.J.

AU - Vingerhoeds, M.H.

AU - Haisma, H.J.

AU - Crommelin, D.J.A.

AU - Storm, G.

N1 - CRC Press, Medpharm GmbH Scient. Publ. Stuttgart, Germany

PY - 1998

Y1 - 1998

M3 - Chapter

SP - 152

EP - 157

BT - Future Strategies for Drug Delivery with Particulate Systems

A2 - Diederichs, J.E.

A2 - Muller, R.H.

ER -